Triton Financial Group Inc bought a new position in shares of Aflac Incorporated (NYSE:AFL - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 16,892 shares of the financial services provider's stock, valued at approximately $1,781,000. Aflac comprises about 1.3% of Triton Financial Group Inc's investment portfolio, making the stock its 24th largest holding.
Several other institutional investors and hedge funds have also made changes to their positions in AFL. Brighton Jones LLC boosted its holdings in shares of Aflac by 64.4% during the 4th quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider's stock worth $1,507,000 after purchasing an additional 5,708 shares during the last quarter. Bison Wealth LLC boosted its holdings in shares of Aflac by 4.3% during the 4th quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider's stock worth $455,000 after purchasing an additional 183 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Aflac by 11.6% during the 1st quarter. GAMMA Investing LLC now owns 13,527 shares of the financial services provider's stock worth $1,504,000 after purchasing an additional 1,411 shares during the last quarter. Advisor Resource Council acquired a new position in Aflac in the first quarter valued at approximately $286,000. Finally, Garde Capital Inc. acquired a new position in Aflac in the first quarter valued at approximately $36,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Aflac
In other news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $102.57, for a total transaction of $102,570.00. Following the sale, the director owned 25,105 shares of the company's stock, valued at approximately $2,575,019.85. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.80% of the company's stock.
Aflac Stock Up 1.0%
NYSE:AFL opened at $108.77 on Tuesday. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. The stock's fifty day moving average is $108.45 and its two-hundred day moving average is $105.41. Aflac Incorporated has a 52 week low of $96.95 and a 52 week high of $115.43. The stock has a market capitalization of $58.17 billion, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 2.99 and a beta of 0.86.
Aflac (NYSE:AFL - Get Free Report) last released its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 EPS for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%.The company had revenue of $5.91 billion for the quarter. Research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.
Aflac announced that its board has authorized a share repurchase program on Tuesday, August 12th that authorizes the company to buyback 100,000,000 outstanding shares. This buyback authorization authorizes the financial services provider to reacquire shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued.
Aflac Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Stockholders of record on Wednesday, August 20th were given a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, August 20th. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.1%. Aflac's dividend payout ratio is currently 52.61%.
Analysts Set New Price Targets
A number of research analysts recently commented on AFL shares. JPMorgan Chase & Co. upped their price objective on Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a report on Tuesday, July 8th. Piper Sandler set a $125.00 price objective on Aflac and gave the company an "overweight" rating in a report on Tuesday, October 7th. UBS Group decreased their price objective on Aflac from $114.00 to $111.00 and set a "neutral" rating on the stock in a report on Wednesday, August 6th. Wells Fargo & Company upped their price objective on Aflac from $105.00 to $107.00 and gave the company an "equal weight" rating in a report on Monday, August 11th. Finally, Keefe, Bruyette & Woods upped their price objective on Aflac from $108.00 to $110.00 and gave the company a "market perform" rating in a report on Thursday, October 9th. Three research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Aflac currently has a consensus rating of "Hold" and a consensus price target of $109.45.
Get Our Latest Analysis on Aflac
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.